Cross-sectional study to evaluate the tocilizumab serum levels and its association with drug dosage and disease activity in rheumatoid arthritis patients

Trial Profile

Cross-sectional study to evaluate the tocilizumab serum levels and its association with drug dosage and disease activity in rheumatoid arthritis patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Jul 2015

At a glance

  • Drugs Tocilizumab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 22 Jul 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top